Home About ATSDR Press Room A-Z Index Glossary Employment Training Contact Us CDC  
ATSDR/DHHS Agency for Toxic Substances and Disease Registry Agency for Toxic Substances and Disease Registry Department of Health and Human Services ATSDR en Español

Search:

Section Contents
 
Learning Objectives
Deprecated Treatments
Key Points
Progress Check
 
Case Contents
 
Table of Contents
Cover Page
How to Use the Course
Initial Check
Mass Casualty Events
Cholinesterase Inhibitors
Pathological Conditions
Cholinergic Toxidrome
Nicotinic Receptors
Muscarinic Receptors
Nicotinic/Muscarinic Mixture
Signs and Symptoms
Laboratory Tests
Differential Diagnosis
Pediatric Cases
Exposure History
RBC & Serum Tests
Inhibitors & Byproducts
Management Strategies
Secondary Exposure
Supportive Care
First-Line Medications
Medications: Atropine
Medications: Pralidoxime
Medications: Diazepam
Antidote Stocking
Medico-Legal Issues
Intermediate Syndrome
Delayed Neuropathy
Chronic Neurotoxicity
Other Issues
Posttest
Literature Cited
 
Related Documents
 
MMG: Nerve Agents
ToxFAQs™: Nerve Agents
 
Case Studies (CSEM)
 
CSEM Home
Continuing Education
Online Registration
 
ATSDR Resources
 
Case Studies (CSEM)
Exposure Pathways
GATHER (GIS)
Health Assessments
Health Statements
Interaction Profiles
Interactive Learning
Managing Incidents
Medical Guidelines
Minimal Risk Levels
Priority List
ToxFAQs™
ToxFAQs™ CABS
Toxicological Profiles
Toxicology Curriculum
 
External Resources
 
CDC
eLCOSH
EPA
Healthfinder®
Medline Plus
NCEH
NIEHS
NIOSH
OSHA
 

Agency for Toxic Substances and Disease Registry
Case Studies in Environmental Medicine (CSEM) 

Cholinesterase Inhibitors
Including Insecticides and Chemical Warfare Nerve Agents
Part 4: The Cholinergic Toxidrome
Section 11: Management of the Cholinergic Toxidrome
Syrup of Ipecac, Gastric Lavage, Cathartics, and Activated Charcoal


Learning Objectives

Upon completion of this section, you should be able to

  • Describe the roles of the following treatment modalities in the management of poisoning due to cholinesterase inhibitors:
    • Syrup of ipecac.
    • Gastric lavage.
    • Cathartics.
    • Activated charcoal.

Treatments No Longer Recommended as Routine Treatments for Poisoning

Data is lacking to show that any of the following treatments improve the outcome in poisoned patients:

  • Activated charcoal.
  • Cathartics.
  • Gastric lavage.
  • Syrup of ipecac.

Furthermore, these treatments can be associated with morbidity. Therefore they are no longer recommended as routine treatments. (American Academy of Clinical Toxicology and European Association of Poison Centres and Clinical Toxicologists 1997)

The presence of vomiting and diarrhea in cholinesterase poisoning would certainly obviate such treatment in any case. Finally, it is contraindicated if the diluent for the cholinesterase inhibitor is a hydrocarbon with high aspiration potential. (Durham and Hayes 1962; American Academy of Clinical Toxicology and European Association of Poison Centres and Clinical Toxicologists 1997; Clark 2002)

While there is no evidence that activated charcoal improves the clinical outcome in poisoning cases, some would consider administrating activated charcoal, if the (American Academy of Clinical Toxicology and European Association of Poison Centres and Clinical Toxicologists 1997)

  • Activated charcoal is given within 1 hour of the ingestion of a potentially toxic dose.
  • Cholinesterase inhibitor is known to be adsorbed by charcoal, and
  • Patient has an intact or protected airway.

Note: Persistent levels of cholinesterase inhibitors have been detected in the gastric contents of some patients suffering from the intermediate syndrome (a delayed manifestation of cholinesterase inhibitor poisoning --- discussed later). (De Bleecker, Van Den Neucker et al. 1993) Although one might conclude that charcoal and gastric emptying might improve outcome for these cases. This has not yet been subjected to empirical study.


Key Points

  • Evidence is lacking to demonstrate that syrup of ipecac, activated charcoal, and cathartics improve outcome in poisoning.

Progress Check

43. For which of the following treatments is there good evidence that they improve the outcome in cases of acute cholinesterase inhibitor poisoning? (Choose ALL correct answers)

A. Activated charcoal.
B. Cathartics.
C. Syrup of ipecac or gastric lavage.
D. None of the above.

Answer:

To review relevant content, see Treatments No Longer Recommended as Routine Treatments for Poisoning in this section.


Previous Section

Next Section

Revised 2007-10-16.